InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- CDY Signs Distribution Agreement for EVOLIS in South Korea 6 Aug 2019 9:04AM $0.215 $0.056 fallen by 73.95%
- Response to Appendix 4C Query 1 Aug 2019 1:21PM $0.220 $0.056 fallen by 74.55%
- Appendix 3B 30 Jul 2019 5:29PM $0.220 $0.056 fallen by 74.55%
- Appendix 4C and Notes to Appendix 4C 26 Jul 2019 8:58AM $0.230 $0.056 fallen by 75.65%
- Cellmid Investor Newsletter 10 Jul 2019 2:13PM $0.235 $0.056 fallen by 76.17%
- Response to ASX Aware Query 8 Jul 2019 10:12AM $0.250 $0.056 fallen by 77.60%
- Cellmid Sets Another Sales Record in Q4 FY2019 4 Jul 2019 2:49PM $0.220 $0.056 fallen by 74.55%
- Change of Director's Interest Notice - Halasz 7 Jun 2019 5:55PM $0.175 $0.056 fallen by 68%
- FY2020 Growth Strategy Update 28 May 2019 9:33AM $0.180 $0.056 fallen by 68.89%
- Cellmid appoints new Lyramid CEO 28 May 2019 9:13AM $0.180 $0.056 fallen by 68.89%
- Minimum Holding Buy-Back Complete - ASIC Form 484 23 May 2019 6:28PM $0.195 $0.056 fallen by 71.28%
- Minimum Holding Buy-Back Closed 21 May 2019 10:12AM $0.195 $0.056 fallen by 71.28%
- Change of Director's Interest Notice - Maria Halasz 6 May 2019 3:51PM $0.195 $0.056 fallen by 71.28%
- Cellmid's Evolis Registered in European Union (EU) 30 Apr 2019 2:22PM $0.195 $0.056 fallen by 71.28%
- Appendix 4C and Notes to Appendix 4C 29 Apr 2019 10:17AM $0.210 $0.056 fallen by 73.33%
- Change of Director's Interest Notice - Halasz 18 Apr 2019 3:58PM $0.220 $0.056 fallen by 74.55%
- Cellmid Alopecia Patent Allowed in Eurpoe 2 Apr 2019 8:59AM $0.235 $0.056 fallen by 76.17%
- Cellmid Investor Newsletter 26 Mar 2019 1:21PM $0.215 $0.056 fallen by 73.95%
- Minimum Holding Share Buy-Back 19 Mar 2019 9:00AM $0.220 $0.056 fallen by 74.55%
- Appendix 4D, Half Year Accounts and Strategy Update 21 Feb 2019 3:15PM $0.250 $0.056 fallen by 77.60%
- Significant New Findings Published on Midkine 7 Feb 2019 11:54AM $0.240 $0.056 fallen by 76.67%
- Appendix 4C and Notes to Appendix 4C 23 Jan 2019 9:31AM $0.275 $0.056 fallen by 79.64%
- Cellmid Expects Record Sales in Q2 FY2019 12 Dec 2018 9:37AM $0.260 $0.056 fallen by 78.46%
- Change of Director's Interest Notice - Halasz 13 Nov 2018 2:15PM $0.350 $0.056 fallen by 84%
- Change of Director's Interest Notice - Eck 13 Nov 2018 2:12PM $0.350 $0.056 fallen by 84%

176 - 200 of 530 results

Page 8 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.